ResearchMoz

Taiwan Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

Publisher Name » GlobalData
Published Date » 2012-05-21
No. Of Pages » 131


GlobalDatas new report, Taiwan Neurology Devices Market Outlook to 2018 Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others provides key market data on the Taiwan Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Market size and company share data for Neurology Devices market categories CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018. 
  • 2011 company shares and distribution shares data for each of the six market categories.
  • Global corporate-level profiles of key companies operating within the Taiwan Neurology Devicesmarket. 
  • Key players covered include Medtronic, Inc., Nihon Kohden Corporation, B. Braun Melsungen AG, Stryker Corporation, DePuy, Inc., Terumo Corporation and others.
Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Taiwan Neurology Devices competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.
Table of Content

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9

2 Introduction 11
2.1 What Is This Report About? 11

3 Neurology Devices In Taiwan 12
3.1 Neurology Devices, Market Segmentation 12
3.2 Neurology Devices, Taiwan, Overall Revenue ($m), USD Constant, 2004-2018 13
3.3 Neurology Devices Market, Taiwan, Revenue Mix ($m), 2011 15
3.4 Neurology Devices Market, Taiwan, Category Contribution (%), 2011 16
3.5 Neurology Devices, Taiwan, Company Share (2010-2011) 23

4 CSF Management In Taiwan 25
4.1 CSF Management, Market Segmentation 25
4.2 CSF Management Market, Taiwan, Revenue Mix ($m), 2011 26
4.3 CSF Management Market, Taiwan, Segment Contribution (%), 2011 27
4.4 CSF Management Overall Revenue, (2004-2018) 28
4.5 CSF Management Overall Volume (2004-2018) 32
4.6 CSF Management Average Price (2004-2018) 34
4.7 CSF Management Distribution Share (2010-2011) 35
4.8 CSF Management, Taiwan, Company Share (2010-2011) 36

5 Interventional Neurology In Taiwan 38
5.1 Interventional Neurology, Market.Segmentation 38
5.2 Interventional Neurology Market, Taiwan, Revenue Mix ($m), 2011 39
5.3 Interventional Neurology Market, Taiwan, Segment Contribution (%), 2011 40
5.4 Interventional Neurology Overall Revenue, (2004-2018) 41
5.4.1 Embolic Systems, Revenue (2004-2018) 45
5.4.2 Navigational Systems, Revenue (2004-2018) 49
5.5 Interventional Neurology Overall Volume (2004-2018) 53
5.5.1 Embolic Systems, Volume (2004-2018) 57
5.5.2 Navigational Systems, Volume (2004-2018) 59
5.6 Interventional Neurology Average Price (2004-2018) 61
5.7 Interventional Neurology Distribution Share (2010-2011) 62
5.8 Interventional Neurology, Taiwan, Company Share (2010-2011) 63

6 Neurological Diagnostic Equipment In Taiwan 65
6.1 Neurological Diagnostic Equipment, Market.Segmentation 65
6.2 Neurological Diagnostic Equipment Market, Taiwan, Revenue Mix ($m), 2011 66
6.3 Neurological Diagnostic Equipment Market, Taiwan, Segment Contribution (%), 2011 67
6.4 Neurological Diagnostic Equipment Overall Revenue, (2004-2018) 68
6.5 Neurological Diagnostic Equipment Overall Volume (2004-2018) 72
6.6 Neurological Diagnostic Equipment Average Price (2004-2018) 76
6.7 Neurological Diagnostic Equipment Distribution Share (2010-2011) 77
6.8 Neurological Diagnostic Equipment, Taiwan, Company Share (2010-2011) 78

7 Neurostimulation Devices In Taiwan 79
7.1 Neurostimulation Devices, Market Segmentation 79
7.2 Neurostimulation Devices Market, Taiwan, Revenue Mix ($m), 2011 80
7.3 Neurostimulation Devices Market, Taiwan, Segment Contribution (%), 2011 81
7.4 Neurostimulation Devices Overall Revenue, (2004-2018) 82
7.5 Neurostimulation Devices Overall Volume (2004-2018) 86
7.6 Neurostimulation Devices Average Price (2004-2018) 88
7.7 Neurostimulation Devices Distribution Share (2010-2011) 89
7.8 Neurostimulation Devices, Taiwan, Company Share (2010-2011) 90

8 Neurosurgical Products In Taiwan 91
8.1 Neurosurgical Products, Market Segmentation 91
8.2 Neurosurgical Products Market, Taiwan, Revenue Mix ($m), 2011 92
8.3 Neurosurgical Products Market, Taiwan, Segment Contribution (%), 2011 93
8.4 Neurosurgical Products Overall Revenue, (2004-2018) 94
8.5 Neurosurgical Products Overall Volume (2004-2018) 98
8.6 Neurosurgical Products Average Price (2004-2018) 100
8.7 Neurosurgical Products Distribution Share (2010-2011) 101
8.8 Neurosurgical Products, Taiwan, Company Share (2010-2011) 102

9 Radiosurgery In Taiwan 103
9.1 Radiosurgery, Market Segmentation 103
9.2 Radiosurgery Overall Revenue, (2004-2011) 104
9.3 Radiosurgery Overall Volume (2004-2011) 106
9.4 Radiosurgery Average Price (2004-2011) 107

10 Overview of Key Companies in Taiwan Neurology Devices Market 108
10.1 Medtronic, Inc. 108
10.1.1 Company Overview 108
10.1.2 Share in the Taiwan Neurology Devices Market 108
10.2 Nihon Kohden Corporation 109
10.2.1 Company Overview 109
10.2.2 Share in the Taiwan Neurology Devices Market 109
10.3 B. Braun Melsungen AG 110
10.3.1 Company Overview 110
10.3.2 Share in the Taiwan Neurology Devices Market 110
10.4 Stryker Corporation 111
10.4.1 Company Overview 111
10.4.2 Share in the Taiwan Neurology Devices Market 111
10.5 DePuy, Inc. 112
10.5.1 Company Overview 112
10.5.2 Share in the Taiwan Neurology Devices Market 112
10.6 Terumo Corporation 113
10.6.1 Company Overview 113
10.6.2 Share in the Taiwan Neurology Devices Market 113
10.7 Covidien plc 114
10.7.1 Company Overview 114
10.8 Natus Medical Incorporated 114
10.8.1 Company Overview 114
10.9 CareFusion Corporation 115
10.9.1 Company Overview 115
10.10 Cadwell Laboratories, Inc. 115
10.10.1 Company Overview 115
10.11 Integra LifeSciences Holdings Corporation 116
10.11.1 Company Overview 116
10.12 Sophysa S.A. 116
10.12.1 Company Overview 116
10.13 Cyberonics, Inc. 117
10.13.1 Company Overview 117
10.14 Boston Scientific Corporation 117
10.14.1 Company Overview 117
10.15 St. Jude Medical, Inc. 118
10.15.1 Company Overview 118
10.16 KARL STORZ GmbH & Co. KG 118
10.16.1 Company Overview 118
11 Neurology Devices Market Pipeline Products 119

12 Appendix 123
12.1 Definitions of Markets Covered in the Report 124
12.1.1 Neurology Devices 124
12.2 Research Methodology 128
12.3 Secondary Research 128
12.4 Primary Research 129
12.5 Models 129
12.6 Forecasts 130
12.7 Expert Panels 130
12.8 GlobalData Consulting 130
12.9 Currency Conversion 131
12.10 Contact Us 131
12.11 Disclaimer 131

List of Tables


Table 1: Neurology Devices, Taiwan, Overall Revenue ($m), USD Constant, 2004-2018 14
Table 2: Neurology Devices Market, Taiwan, Category Contribution (%), 2011 16
Table 3: Neurology Devices, Taiwan, Overall Revenue ($m), USD Constant, 2004-2018 18
Table 4: Neurology Devices, Taiwan, Overall Revenue ($m), USD Constant, Historic, 2004-2011 20
Table 5: Neurology Devices, Taiwan, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 22
Table 6: Neurology Devices, Taiwan, Company Share by Revenue ($m), USD Constant, 2010-2011 24
Table 7: CSF Management Market, Taiwan, Segment Contribution (%), 2011 27
Table 8: CSF Management, Taiwan, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 29
Table 9: CSF Management, Taiwan, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 31
Table 10: CSF Management, Taiwan, Volume (Units) by Segment, Historic, 2004-2011 32
Table 11: CSF Management, Taiwan, Volume (Units) by Segment, Forecast, 2011-2018 33
Table 12: CSF Management, Taiwan, Average Price ($), Historic, 2004-2011 34
Table 13: CSF Management, Taiwan, Average Price ($), Forecast, 2011-2018 34
Table 14: CSF Management, Taiwan, Distribution Share by Revenue ($m), USD Constant, 2010-2011 35
Table 15: CSF Management, Taiwan, Company Share by Revenue ($m), USD Constant, 2010-2011 37
Table 16: Interventional Neurology Market, Taiwan, Segment Contribution (%), 2011 40
Table 17: Interventional Neurology, Taiwan, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 42
Table 18: Interventional Neurology, Taiwan, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 44
Table 19: Embolic Systems, Taiwan, Revenue ($m*) USD Constant, by Sub-Segment, Historic, 2004-2011 46
Table 20: Embolic Systems, Taiwan, Revenue ($m*) USD Constant, by Sub-Segment, Forecast, 2011-2018 48
Table 21: Navigational Systems, Taiwan, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 50
Table 22: Navigational Systems, Taiwan, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 52
Table 23: Interventional Neurology, Taiwan, Volume (Units) by Segment, Historic, 2004-2011 54
Table 24: Interventional Neurology, Taiwan, Volume (Units) by Segment, Forecast, 2011-2018 56
Table 25: Embolic Systems, Taiwan, Volume (Units) by Sub-Segment, Historic, 2004-2011 57
Table 26: Embolic Systems, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2011-2018 58
Table 27: Navigational Systems, Taiwan, Volume (Units) by Sub-Segment, Historic, 2004-2011 59
Table 28: Navigational Systems, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2011-2018 60
Table 29: Interventional Neurology, Taiwan, Average Price ($), Historic, 2004-2011 61
Table 30: Interventional Neurology, Taiwan, Average Price ($), Forecast, 2011-2018 61
Table 31: Interventional Neurology, Taiwan, Distribution Share by Revenue ($m), USD Constant, 2010-2011 62
Table 32: Interventional Neurology, Taiwan, Company Share by Revenue ($m), USD Constant, 2010-2011 64
Table 33: Neurological Diagnostic Equipment Market, Taiwan, Segment Contribution (%), 2011 67
Table 34: Neurological Diagnostic Equipment, Taiwan, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 69
Table 35: Neurological Diagnostic Equipment, Taiwan, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 71
Table 36: Neurological Diagnostic Equipment, Taiwan, Volume (Units) by Segment, Historic, 2004-2011 73
Table 37: Neurological Diagnostic Equipment, Taiwan, Volume (Units) by Segment, Forecast, 2011-2018 75
Table 38: Neurological Diagnostic Equipment, Taiwan, Average Price ($), Historic, 2004-2011 76
Table 39: Neurological Diagnostic Equipment, Taiwan, Average Price ($), Forecast, 2011-2018 76
Table 40: Neurological Diagnostic Equipment, Taiwan, Distribution Share by Revenue ($m), USD Constant, 2010-2011 77
Table 41: Neurological Diagnostic Equipment, Taiwan, Company Share by Revenue ($m), USD Constant, 2010-2011 78
Table 42: Neurostimulation Devices Market, Taiwan, Segment Contribution (%), 2011 81
Table 43: Neurostimulation Devices, Taiwan, Revenue ($m*) USD Constant, by Segment, Historic, 2004-2011 83
Table 44: Neurostimulation Devices, Taiwan, Revenue ($m*) USD Constant, by Segment, Forecast, 2011-2018 85
Table 45: Neurostimulation Devices, Taiwan, Volume (Units) by Segment, Historic, 2004-2011 86
Table 46: Neurostimulation Devices, Taiwan, Volume (Units) by Segment, Forecast, 2011-2018 87
Table 47: Neurostimulation Devices, Taiwan, Average Price ($), Historic, 2004-2011 88
Table 48: Neurostimulation Devices, Taiwan, Average Price ($), Forecast, 2011-2018 88
Table 49: Neurostimulation Devices, Taiwan, Distribution Share by Revenue ($m), USD Constant, 2010-2011 89
Table 50: Neurostimulation Devices, Taiwan, Company Share by Revenue ($m), USD Constant, 2010-2011 90
Table 51: Neurosurgical Products Market, Taiwan, Segment Contribution (%), 2011 93
Table 52: Neurosurgical Products, Taiwan, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 95
Table 53: Neurosurgical Products, Taiwan, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 97
Table 54: Neurosurgical Products, Taiwan, Volume (Units) by Segment, Historic, 2004-2011 98
Table 55: Neurosurgical Products, Taiwan, Volume (Units) by Segment, Forecast, 2011-2018 99
Table 56: Neurosurgical Products, Taiwan, Average Price ($), Historic, 2004-2011 100
Table 57: Neurosurgical Products, Taiwan, Average Price ($), Forecast, 2011-2018 100
Table 58: Neurosurgical Products, Taiwan, Distribution Share by Revenue ($m), USD Constant, 2010-2011 101
Table 59: Neurosurgical Products, Taiwan, Company Share by Revenue ($m), USD Constant, 2010-2011 102
Table 60: Radiosurgery, Taiwan, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 105
Table 61: Radiosurgery, Taiwan, Volume (Units) by Segment, Historic, 2004-2011 106
Table 62: Radiosurgery, Taiwan, Average Price ($), Historic, 2004-2011 107
Table 63: Neurology Devices Market Pipeline Products 119

List of Figures


Figure 1: Neurology Devices, Market Segmentation 12
Figure 2: Neurology Devices, Taiwan, Overall Revenue ($m), USD Constant, 2004-2018 13
Figure 3: Neurology Devices Market, Taiwan, Revenue Mix ($m), 2011 15
Figure 4: Neurology Devices Market, Taiwan, Category Contribution (%), 2011 16
Figure 5: Neurology Devices, Taiwan, Cross-Category Analysis, 2004-2018 17
Figure 6: Neurology Devices, Taiwan, Overall Revenue ($m), USD Constant, Historic, 2004-2011 19
Figure 7: Neurology Devices, Taiwan, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 21
Figure 8: Neurology Devices, Taiwan, Company Share (%), 2011 23
Figure 9: CSF Management, Market Segmentation 25
Figure 10: CSF Management Market, Taiwan, Revenue Mix ($m), 2011 26
Figure 11: CSF Management Market, Taiwan, Segment Contribution (%), 2011 27
Figure 12: CSF Management, Taiwan, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 28
Figure 13: CSF Management, Taiwan, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 30
Figure 14: CSF Management, Taiwan, Volume (Units) by Segment, Historic, 2004-2011 32
Figure 15: CSF Management, Taiwan, Volume (Units) by Segment, Forecast, 2011-2018 33
Figure 16: CSF Management, Taiwan, Company Share (%), 2011 36
Figure 17: Interventional Neurology, Market Segmentation 38
Figure 18: Interventional Neurology Market, Taiwan, Revenue Mix ($m), 2011 39
Figure 19: Interventional Neurology Market, Taiwan, Segment Contribution (%), 2011 40
Figure 20: Interventional Neurology, Taiwan, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 41
Figure 21: Interventional Neurology, Taiwan, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 43
Figure 22: Embolic Systems, Taiwan, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 45
Figure 23: Embolic Systems, Taiwan, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 47
Figure 24: Navigational Systems, Taiwan, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 49
Figure 25: Navigational Systems, Taiwan, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 51
Figure 26: Interventional Neurology, Taiwan, Volume (Units) by Segment, Historic, 2004-2011 53
Figure 27: Interventional Neurology, Taiwan, Volume (Units) by Segment, Forecast, 2011-2018 55
Figure 28: Embolic Systems, Taiwan, Volume (Units) by Sub-Segment, Historic, 2004-2011 57
Figure 29: Embolic Systems, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2011-2018 58
Figure 30: Navigational Systems, Taiwan, Volume (Units) by Sub-Segment, Historic, 2004-2011 59
Figure 31: Navigational Systems, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2011-2018 60
Figure 32: Interventional Neurology, Taiwan, Company Share (%), 2011 63
Figure 33: Neurological Diagnostic Equipment, Market Segmentation 65
Figure 34: Neurological Diagnostic Equipment Market, Taiwan, Revenue Mix ($m), 2011 66
Figure 35: Neurological Diagnostic Equipment Market, Taiwan, Segment Contribution (%), 2011 67
Figure 36: Neurological Diagnostic Equipment, Taiwan, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 68
Figure 37: Neurological Diagnostic Equipment, Taiwan, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 70
Figure 38: Neurological Diagnostic Equipment, Taiwan, Volume (Units) by Segment, Historic, 2004-2011 72
Figure 39: Neurological Diagnostic Equipment, Taiwan, Volume (Units) by Segment, Forecast, 2011-2018 74
Figure 40: Neurological Diagnostic Equipment, Taiwan, Company Share (%), 2011 78
Figure 41: Neurostimulation Devices, Market Segmentation 79
Figure 42: Neurostimulation Devices Market, Taiwan, Revenue Mix ($m), 2011 80
Figure 43: Neurostimulation Devices Market, Taiwan, Segment Contribution (%), 2011 81
Figure 44: Neurostimulation Devices, Taiwan, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 82
Figure 45: Neurostimulation Devices, Taiwan, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 84
Figure 46: Neurostimulation Devices, Taiwan, Volume (Units) by Segment, Historic, 2004-2011 86
Figure 47: Neurostimulation Devices, Taiwan, Volume (Units) by Segment, Forecast, 2011-2018 87
Figure 48: Neurostimulation Devices, Taiwan, Company Share (%), 2011 90
Figure 49: Neurosurgical Products, Market Segmentation 91
Figure 50: Neurosurgical Products Market, Taiwan, Revenue Mix ($m), 2011 92
Figure 51: Neurosurgical Products Market, Taiwan, Segment Contribution (%), 2011 93
Figure 52: Neurosurgical Products, Taiwan, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 94
Figure 53: Neurosurgical Products, Taiwan, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 96
Figure 54: Neurosurgical Products, Taiwan, Volume (Units) by Segment, Historic, 2004-2011 98
Figure 55: Neurosurgical Products, Taiwan, Volume (Units) by Segment, Forecast, 2011-2018 99
Figure 56: Neurosurgical Products, Taiwan, Company Share (%), 2011 102
Figure 57: Radiosurgery, Market Segmentation 103
Figure 58: Radiosurgery, Taiwan, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 104
Figure 59: Radiosurgery, Taiwan, Volume (Units) by Segment, Historic, 2004-2011 106
Figure 60: Medtronic, Inc., Company Share (%),Taiwan Neurology Devices Market, 2011 108
Figure 61: Nihon Kohden Corporation, Company Share (%),Taiwan Neurology Devices Market, 2011 109
Figure 62: B. Braun Melsungen AG, Company Share (%),Taiwan Neurology Devices Market, 2011 110
Figure 63: Stryker Corporation, Company Share (%),Taiwan Neurology Devices Market, 2011 111
Figure 64: DePuy, Inc., Company Share (%),Taiwan Neurology Devices Market, 2011 112
Figure 65: Terumo Corporation, Company Share (%),Taiwan Neurology Devices Market, 2011 113

Upcoming Reports:

Fiber Optic Sensors Market- Global Forecast, Market Share, Size, Growth And Industry Analysis (2012-2018)
By - Transparency Market Research
Today, most applications use fiber optic sensor technology. The major factors accountable for driving the fiber optic sensor market are their small size, low power consumption, resistance to electromagnetic interference, and high sensitivity. Technological improvements in terms of increased efficiency and performance have helped in driving the growth of fiber optic sensors. Ongoing technological advancements in the areas of telecommunications and local area networks are expected to boost the market growth rate considerably over the next few years. There is also an increasing demand...
Intelligent Highway Market - Global Scenario, Trends, Industry Analysis, Size, Share, And Forecast, 2012 - 2018
By - Transparency Market Research
The two most important aspects associated with an intelligent highway are the safety of vehicles and individuals. Use of navigation systems, use of telematics in vehicles, tolling of roads and highways, congestion avoidance, and location services are all associated with an intelligent highway market. The modern approach to highway travel has been driving the market of the intelligent highway. Goods are transported, workers commute, and there are a plethora of other factors responsible for creating the need for an intelligent highway. Apart from these factors, safety of...
Social Network Advertising Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
By - Transparency Market Research
Social networking advertising is the means of gaining attention of customers by utilizing social networking portals. Increasing use of internet and social media have forced marketers to find better ways of communication and engagement with customers so as to increase the efficiency of advertising, increase their customer base and create loyal customers. The global social media market reported USD 11.78billion revenue in 2011 and this is expected to increase to USD 17 billion in 2012. In this market, the major contribution of 60% by the social networking advertising...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...